首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION AND EVALUATION OF CELECOXIB GEL
【24h】

FORMULATION AND EVALUATION OF CELECOXIB GEL

机译:塞来昔布凝胶的配方与评价

获取原文
       

摘要

The present research has been undertaken with the aim to develop a topical gel formulation of celecoxib, which would attenuate the gastrointestinal relater toxicities associated with oral administration and to investigate the effect of DMSO on permeation of celecoxib. Celecoxib is a highly selective cyclooxygenase-2 (cox-2) inhibitor. In the present study gel with different concentrations of carbapol, sodium alginate and sodium carboxy methylcellulose were prepared. Gels were subjected for various evaluation tests such as pH measurement, spreadibility and extrudability. In-vitro dissolution studies were performed in phosphate buffer of pH 5.6 and polyethylene glycol 400 (7.4 pH) for 12 hrs by using Keshary-Chien diffusion cell apparatus. The gel formulation consisting of 7.5% w/w sodium alginate with DMSO found to be suitable for topical application based on in vitro evaluation. Sodium alginate based gels with DMSO revealed of 90% cumulative drug release after 12 hours. From the above observations, Sodium alginate seems to be a promising pharmaceutical adjuvant in the formulation of celecoxib gels
机译:进行本研究的目的是开发塞来昔布的局部凝胶制剂,该制剂可减轻与口服给药相关的胃肠道相关毒性,并研究DMSO对塞来昔布渗透的影响。塞来昔布是一种高度选择性的环氧合酶2(cox-2)抑制剂。在本研究中,制备了具有不同浓度的咔唑,海藻酸钠和羧甲基纤维素钠的凝胶。对凝胶进行各种评估测试,例如pH测量,铺展性和可挤出性。使用Keshary-Chien扩散池仪器在pH 5.6的磷酸盐缓冲液和聚乙二醇400(7.4 pH)中进行了12小时的体外溶出研究。基于体外评估,发现由7.5%w / w海藻酸钠和DMSO组成的凝胶制剂适用于局部应用。基于藻酸钠的DMSO凝胶显示12小时后累积90%的药物释放。从以上观察结果来看,海藻酸钠似乎是塞来昔布凝胶制剂中有希望的药物佐剂

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号